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Abstract
A new member of the ABC superfamily of transmembrane proteins in Aspergillus nidulans has been cloned and
characterized. The topology of conserved motifs subgroups AtrC in the P-glycoprotein cluster of ABC permeases, the
members of this subfamily, are known to participate in multidrug resistance (MDR) in diverse organisms. Alignment results
display significant amino acid similarity to AfuMDR1 and AflMDR1 from Aspergillus fumigatus and flavus, respectively.
Northern analysis reveals that atrC mRNA levels are 10-fold increased in response to cycloheximide. Evidence for the
existence of eight additional hitherto unpublished ABC transporter proteins in A. nidulans is provided. ß 1999 Elsevier
Science B.V. All rights reserved.
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The ATP binding cassette (ABC) superfamily rep-
resents a transporter system with ubiquitous occur-
rence in all classi¢cations of living organisms. In
general, the ABC transporters are multicomponent
transmembrane proteins which couple the energy of
ATP hydrolysis to the selective transfer of substrates
across biological membranes [1]. Each permease is
speci¢c for a substrate or group of related substrates
ranging from natural products (e.g. small molecules
such as anorganic ions, sugars, amino acids up to
larger ones like polypeptides) to xenobiotics (e.g.
antitumor or antifungal drugs), which are subject to
either export or import [2]. ABC transporters can be
localized in the plasma membrane as well as in the
membranes of intracellular organelles (endoplasmic
reticulum, vacuole, peroxisome or mitochondria).
To date, more than 150 ABC transporters have
been identi¢ed in diverse organisms including bacte-
ria, yeast, ¢lamentous fungi, protozoa, insects, mam-
mals and plants. For instance, the analysis of the
complete yeast genome predicts the existence of 29
genes encoding putative ABC transporters in Saccha-
romyces cerevisiae [3,4]. Some of them (e.g. YCF1,
PDR5, SNQ2, or YOR1) have been demonstrated to
confer a multidrug resistance (MDR) phenotype [5^
9], a phenomenon originally described in tumor cell
lines which exhibit a simultaneously acquired cross-
resistance to a spectrum of functionally and structur-
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ally unrelated toxic compounds induced by the treat-
ment with a single toxin [10,11].
The genus of the ¢lamentous fungus Aspergillus
comprises several facultative pathogenic species
which can potentially cause life-threatening diseases
in immunocompromised patients. These fungal infec-
tions are di⁄cult to treat with currently available
antifungal agents owing to the toxicity of amphoter-
icin B and resistances to azoles [12,13]. Therefore, the
investigation of the underlying resistance mecha-
nisms is of great clinical importance. Since it has
turned out that the phenomenon of MDR in a vari-
ety of organisms is due to ABC transporter-depend-
ent detoxifying mechanisms, it appears consistent to
hypothesize that the capability of Aspergillus to resist
antifungal treatment is at least in part based upon
such mechanisms. Although A. nidulans is less fre-
quently found in clinical isolates of patients with in-
vasive pulmonary aspergillosis, with A. fumigatus as
the most frequently isolated and virulent species [14],
A. nidulans o¡ers the advantage of suitability for
classical genetic analysis.
In contrast to S. cerevisiae only ¢ve ABC trans-
porters have been identi¢ed so far in the genus As-
pergillus ^ AfuMDR1 and AfuMDR2 in A. fumiga-
tus, A£MDR1 in A. £avus [15], and AtrA as well as
AtrB in A. nidulans [16]. However, a homology
search of the A. nidulans extended sequence tag
(EST) database [17] revealed the presence of at least
eight additional putative members of the ABC pro-
tein family, di¡erent from AtrA an AtrB. Moreover,
an ABC transporter encoding gene (atrC) ^ not de-
tectable in the EST database ^ was cloned in our
laboratory in the course of an unrelated project
(see below). Fig. 1 displays the alignment of the ami-
no acid sequences of 10 EST clones referred to the
C-terminal half of AtrC. One cannot exclude the
possibility that the clones m6e09a1.r1 and
v3g10a1.f1 are N-terminally located sequence
stretches of the same genes as the clones r4g06a1.f1
Fig. 1. Alignment of the deduced amino acid sequences of A. nidulans EST clones and the C-terminal half of AtrC. For each EST
clone several BLAST searches at the nucleotide as well as amino acid level were performed exhibiting signi¢cant similarity to several
already described ABC transporters. Computational alignment was generated employing the CLUSTAL W program.
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and k9.b08a1.f1. The same argument could be ap-
plied for e4a06a1.r1, but since alignment results dis-
play a homology pattern di¡erent from all the other
clones presented, it has been regarded as an inde-
pendent ABC transporter representing clone. There-
fore, the total number of additional putative ABC
permeases has been estimated as at least eight. Note-
worthy, BLAST searches in the EST database re-
sulted in substantially more clones as presented in
Fig. 1. However, comparative analysis of all detected
clones revealed redundant occurrence. Table 1 sub-
sumes these redundant clones in relation to the
aligned clones of Fig. 1 and presents the respective
ABC transporter proteins with the highest similarity
to each clone.
A previously cloned cDNA fragment encoding a
nucleotide binding domain (NBD), typical for ABC
transporters, was used to screen an A. nidulans cos-
mid library constructed in pWE15 provided by the
Fungal Genetic Stock Center (FGSC) [18]. The ra-
diolabeled DNA probe detected four cosmids ^ W05/
A06, W31/E10, W21/A03 and W11/E04. The latter
three have already been mapped to chromosome II
whereas the insert of W05/A06 had not been assigned
to any particular chromosome so far. Since W31/E10
is part of the minimal physical map of the A. nidu-
lans genome [19], atrC can be localized to the right
arm of chromosome II. Subsequently, a 4-kb NarI
fragment from W21/A03 (Fig. 2A) covering the
greater party of atrC was subcloned in pBluescript
KS3 (Stratagene, San Diego, CA) and entirely se-
quenced employing the Taq-cycle procedure (Per-
kin-Elmer, Norwalk, CT). In order to obtain the
full-length gene, the 5P end was sequenced directly
from cosmid W21/A03.
Comparison of the genomic and cDNA sequences,
the latter generated by reverse transcribed (RT)-
PCR, revealed the presence of an open reading frame
(ORF) of 3882 bp punctuated by two introns, 56 and
66 bp in length, with exon/intron splice sequences
and intron sizes typical for ¢lamentous fungi [20].
In a£MDR1 and afuMDr1 the positions of two in-
Table 1
Overview of the detected EST clones of A. nidulans encoding putative ABC proteins
A. nidualans EST clone
aligned with AtrC
Redundant A. nidulans
EST clone(s) in database
ABC transporter protein displaying highest similarity
to the respective EST clone
m6e09a1.r1 a5e07a1.f1 AfuMDR1 (U62933)
i2d06a1.f1
d5h04a1.r1, d5h04a1.f1
j7c08a1.f1
v3e10a1.f1
v4e10a1.f1
w7c07a1.f1
v3g10a1.f1 d5g10a1.¢, d5g10a1.r1 AfuMDR1 (U62933)
e4a06a1.r1 e4a06a1.f1 hypothetical ABC transporter Rv1349 of Mycobacterium
tuberculosis (Z75555)
m7h09a1.f1, m7h09a1.r1
c9e04a1.f1 ^ CnMDR1 (U62929)
o8f05a1.f1 ^ P-gp2 of Entamoeba histolytica (M88598)
g3c12a1.r1 j9b01a1.f1 PMR1 of Penicillium digitatum (AB010442)
k5e11a1.r1
s3f01a1.f1 ^ PMR1 of Penicillium digitatum (AB010442)
c8e02a1.r1 c8e02a1.f1 ABC1 of Magnaporthe grisea (AF032443)
c3a08a1.r1
r4g06a1.f1 i7b11a1.f1 AfuMDR1 (U62933)
j4c05a1.f1
v1h02a1.r1
r4g06a1.r1
k9b08a1.f1 ^ AfuMDR1 (U62933)
The redundant clones are grouped in correlation to the aligned clones of Fig. 1 and the ABC transporter protein with the highest sim-
ilarity to the respective EST clone group is presented.
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trons are perfectly conserved; in contrast atrC dis-
plays a completely di¡erent intron/exon structure
(Fig. 2A). Since the intron positions of correspond-
ing genes within plectomycetes are generally con-
served, atrC can be speculated to be a representative
of a di¡erent subgroup. The ORF of atrC encodes a
protein of 1293 amino acids with a calculated molec-
ular mass of 141.6 kDa. The deduced amino acid
sequence encompasses the core features of ABC pro-
teins ^ transmembrane (TM) domains and NBDs.
Hydrophobicity [21] and homology analyses suggest
the presence of two hydrophobic TM domains, each
consisting of six membrane-spanning segments (pu-
tative K-helices), and two hydrophilic NBDs [22].
Fig. 2. (A) Restriction map of atrC. (B) Schematic comparison of AtrC and ABC transporters with high similarity. The NBD (gray
boxed) and TM domains (open boxed) are schematically compared with respect to their position within each protein. The numbers
within the boxes indicate the level of amino acid identity (in percent) relative to AtrC. The length of each protein in amino acid resi-
dues (aa) and the overall identity relative to AtrC are given. The arrows indicate the intron positions in atrC, AfuMDR1 and
a£MDR1. (C) Comparison between the N-terminal NBD core motif of ArtC and the other ABC proteins. Amino acid residues that
are identical in at least ¢ve of seven proteins are black boxed, the Walker motifs and the ABC signature are marked by lines. Amino
acid residues £anking both sides of the N-terminal NBD are presented to display that similarity is not exclusively con¢ned to the core
domain. A very similar situation exists in the C-terminal NBD.
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Each NBD comprises the highly conserved ‘ABC
signature’, surrounded by the ATP binding motifs
‘Walker A’ and ‘Walker B’ [23]. Therefore, the en-
coded protein displays the same characteristic ar-
rangement of its structural elements as other mem-
bers of the MDR subgroup of eukaryotic ABC
transporters, typi¢ed by the mammalian P-glycopro-
teins. Like many eukaryotic ABC transporters, AtrC
contains its two basic structural domains tandemly
repeated (TM-NBD)2 in a single polypeptide (Fig.
2A,B).
Computational analysis employing the PSORT
program [24] predicts AtrC to be integrated in the
plasma membrane (reliability of 78.3%) with the N-
terminus internally orientated. Using BLAST analy-
sis [25] and the CLUSTAL W alignment program
[26], AtrC exhibits strong similarity to other mem-
bers of the ABC superfamily, in particular to
AfuMDR1, A£MDR1, PMD1 ^ the leptomycin B
resistance protein of Schizosaccharomyces pombe
[27], CneMDR1 of Cryptococcus neoformans [28]
and to the human MDR1 (P-gp) [29] (Fig. 2B,C).
These proteins have been suggested or experimentally
con¢rmed to confer a multidrug phenotype in their
species. Since the analysis of the complete yeast ge-
nome predicts the existence of 29 genes encoding
putative ABC permeases in S. cerevisiae, a speci¢c
search for the best matching yeast ortholog of
AtrC was employed. Computational analysis of the
S. cerevisiae database identi¢ed STE6 ^ the well es-
tablished transporter of the a-factor mating phero-
mone [30,31] ^ as the ABC protein with the highest
similarity to AtrC in yeast. A multisequence align-
ment of the N-terminal NBDs of AtrC and the re-
spective ABC transporters is presented in Fig. 2C.
The regions with the highest level of sequence iden-
tity (40^61%) are centered on the two NBDs, each
spanning a cassette of about 180 amino acids. With
the exception of STE6, considerable similarity exists
also for the TM domains, with identities up to
32.7%. In contrast, AtrC exhibits only weak similar-
ity to AtrA and AtrB. Since these two proteins have
their tandem repeats of TM regions and NBDs ar-
ranged in an inverted manner (NBD-TM)2 compared
to AtrC and many other eukaryotic ABC transport-
ers, where the hydrophobic motifs precede the hydro-
philic ones (TM-NBF)2, this is not surprising.
Noteworthy, BLAST searches in several databases
display a signi¢cant nucleotide identity between the
3P non-coding region of atrC and the unidenti¢ed
reading frame (URF) 4 mitochondrial nucleotide se-
quence of A. nidulans [32] as well as URF1 from
Neurospora crassa [33], with identities of 66 out of
69 nucleotides (nt) for URF4 and 57 out of 69 nt for
URF1 (Fig. 3). Both URFs have their homologs in
mammals. According to the endosymbiotic theory,
genetic exchanges between mitochondria and nuclei
of eukaryotic cells have occurred continuously dur-
ing evolution. Since mitochondrial DNA fragments
have been found in nuclear DNAs of diverse organ-
isms [34,35], one can speculate that this nucleotide
sequence has also been transferred followed by evo-
lutionary divergence.
Fig. 3. Nucleotide alignment between a portion of the 3P non-
coding region of atrC and two URFs from A. nidulans and N.
crassa. Striking identity exists with 66 out of 69 nt (96%) and
49 out of 54 nt (91%). Identical nucleotides in all three sequen-
ces are boxed and shaded. Both URF4 and URF1 are antisense
orientated with respect to the presented sequence stretch of
atrC. The numbering refers to the nt position relative to the
atrC stop codon. The GenBank accession numbers are X03280
for URF1 and V00650 for URF4.
Fig. 4. Northern analysis of A. nidulans atrC gene expression.
Lanes 1^5 represent RNAs isolated after a 1 h treatment of the
mycelia with amphotericin B (7 Wg/ml) (1), cycloheximide (200
Wg/ml) (2), acri£avine (6 Wg/ml) (3), and imidazole (1 Wg/ml)
(4). Lane 5 corresponds to RNA extracted from untreated my-
celium. Subsequent to hybridization with an atrC probe the
blot was stripped and hybridized with a radiolabeled fragment
of the A. nidulans actin encoding gene as control for loading
and quality of the RNAs.
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In order to determine the copy number of atrC in
the genome of A. nidulans, Southern blot analysis
was performed. The hybridization pattern revealed
that A. nidulans harbors atrC as a single copy gene
(data not shown).
Since AtrC shares considerable amino acid similar-
ity to ABC transporters with known MDR pheno-
type it is tempting to speculate on a similar function
for AtrC or at least that it confers resistance to one
or several antifungal agents. Therefore, Northern
analysis was performed to study the expression pat-
tern in response to diverse drugs. A. nidulans strain
FGSC A4 (Glasgow wild type) was grown in liquid
Aspergillus minimal medium [36] at 37‡C for 18 h in
a rotary shaker and subsequently exposed to a lim-
ited number of antifungal drugs for 1 h. Harvesting
of mycelia was followed by RNA extraction, blotting
and hybridization with a radiolabeled DNA probe
from the coding region of atrC. Northern analysis
exhibits 10-fold enhanced mRNA levels of atrC after
exposure to cycloheximide compared to untreated
controls. However, no signi¢cant di¡erences between
untreated controls and RNAs from mycelia exposed
to acri£avine, imidazole or amphotericin B could be
measured under the conditions tested (Fig. 4). The
determined transcript size of 4.2 kb corresponds well
with the proposed length of the coding region. The
quanti¢cation of the signal intensities was performed
using a Phosphor Storage Imaging System, model
Storm 840 (Molecular Dynamics, Sunnyvale, CA,
USA). In contrast to other fungi such as S. cerevisiae
or N. crassa, A. nidulans displays intrinsic resistance
to cycloheximide. Coquejo de Souza et al. [37] re-
cently isolated and genetically characterized 15 cyclo-
heximide-sensitive mutants of A. nidulans which can
be classi¢ed into at least six linkage groups. Since
cycloheximide enhances transcription of atrC ^ as
determined by Northern analysis ^ it is conceivable
that the encoded ABC transporter is at least in part
based on overexpression of atrC in vivo. Cyclohex-
imide was also shown to increase transcription of
atrB while only exhibiting a weak e¡ect on the ex-
pression of atrA, underscoring that this compound is
able to activate multiple transporter systems [16].
In summary, atrC encodes an ABC transporter
protein, its topology subgroups AtrC in the P-gp
cluster of ABC permeases. The members of this sub-
family are known to participate in an MDR pheno-
type in diverse (micro)organisms. Northern analysis
provides evidence that atrC mRNA levels are 10-fold
increased in response to cycloheximide. A. nidulans
o¡ers a convenient model for studying the role of
ABC proteins in ¢lamentous fungi, since this species
is suitable for classical and recombinant fungal ge-
netics besides taking part in human infections. Con-
sequently, the functional characterization of the en-
tire network of ABC permeases in A. nidulans should
be a useful approach in unraveling the contribution
of these potentially detoxifying proteins to the basic
mechanisms of antifungal resistance and MDR in
general. The compilation of the putative ABC trans-
porter encoding EST clones appears to o¡er a possi-
ble means to this approach.
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